Fig. 8From: Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo EvaluationTET concentration-time profiles when 200 μL was topically administered at a dose of 1.0 mg/mL in the aqueous humor (n = 3)Back to article page